Kangstem Biotech Co., Ltd. (KOSDAQ: A217730)
Health Care · Biotechnology · KR
₩2,065.00
-7.81% today · +41.1% 1Y
Kangstem Biotech Co., Ltd. (KOSDAQ: A217730) operates in the Biotechnology industry within the Health Care sector. The company is valued at $144.47M.
Over the last twelve months the share price has gained 41.1%, trading between 1.37K and 4.69K.
Tweenvest scores Kangstem Biotech Co., Ltd. across four factors: quality 41/100, value 70/100, growth 0/100. Its strongest factor is value.
A217730 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $144.47M
- Revenue (TTM)
- $1.96M
- P/E
- —
- EPS
- -130.78
- Dividend yield
- —
- Beta (5Y)
- 0.40
- 52-week high
- ₩4,690.00
- 52-week low
- ₩1,372.00
- Avg volume (3M)
- —
- Shares outstanding
- 94.05M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Actinogen Medical LimitedASX: ACW | $147.68M | AU$0.06 | +1.85% |
| JW (Cayman) Therapeutics Co. LtdSEHK: 2126 | $146.12M | HK$2.83 | +5.21% |
| Acumen Pharmaceuticals, Inc.NasdaqGS: ABOS | $146.08M | $2.02 | -5.61% |
| CANbridge Pharmaceuticals Inc.SEHK: 1228 | $145.79M | HK$1.92 | -6.59% |
| Atrium Therapeutics, Inc.NasdaqGS: RNA | $143.69M | $8.21 | -2.26% |
| UnicoCell Biomed Co., Ltd.TWSE: 6794 | $142.50M | NT$71.60 | -9.25% |
| Outlook Therapeutics, Inc.NasdaqCM: OTLK | $142.44M | $0.59 | -2.30% |
| Cloudbreak Pharma Inc.SEHK: 2592 | $140.32M | HK$— | — |
Figures last refreshed Oct 11, 2026.